Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 30

1.

Biochemical and structural characterization of Cryptosporidium parvum Lactate dehydrogenase.

Cook WJ, Senkovich O, Hernandez A, Speed H, Chattopadhyay D.

Int J Biol Macromol. 2015 Mar;74:608-19. doi: 10.1016/j.ijbiomac.2014.12.019. Epub 2014 Dec 24.

PMID:
25542170
2.

Structure of Streptococcus agalactiae glyceraldehyde-3-phosphate dehydrogenase holoenzyme reveals a novel surface.

Ayres CA, Schormann N, Senkovich O, Fry A, Banerjee S, Ulett GC, Chattopadhyay D.

Acta Crystallogr F Struct Biol Commun. 2014 Oct;70(Pt 10):1333-9. doi: 10.1107/S2053230X14019517. Epub 2014 Sep 25.

PMID:
25286935
3.

Crystallization and preliminary X-ray diffraction analysis of three recombinant mutants of Vaccinia virus uracil DNA glycosylase.

Sartmatova D, Nash T, Schormann N, Nuth M, Ricciardi R, Banerjee S, Chattopadhyay D.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2013 Mar 1;69(Pt 3):295-301. doi: 10.1107/S1744309113002716. Epub 2013 Feb 23.

4.

Crystal structure of Cryptosporidium parvum pyruvate kinase.

Cook WJ, Senkovich O, Aleem K, Chattopadhyay D.

PLoS One. 2012;7(10):e46875. doi: 10.1371/journal.pone.0046875. Epub 2012 Oct 9.

5.

Structure of the catalytic domain of Plasmodium falciparum ARF GTPase-activating protein (ARFGAP).

Cook WJ, Senkovich O, Chattopadhyay D.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2011 Nov 1;67(Pt 11):1339-44. doi: 10.1107/S1744309111032507. Epub 2011 Oct 25.

6.

Identification of protein-protein interaction inhibitors targeting vaccinia virus processivity factor for development of antiviral agents.

Schormann N, Sommers CI, Prichard MN, Keith KA, Noah JW, Nuth M, Ricciardi RP, Chattopadhyay D.

Antimicrob Agents Chemother. 2011 Nov;55(11):5054-62. doi: 10.1128/AAC.00278-11. Epub 2011 Aug 15.

7.

Crystal structure of Plasmodium falciparum phosphoglycerate kinase: evidence for anion binding in the basic patch.

Smith CD, Chattopadhyay D, Pal B.

Biochem Biophys Res Commun. 2011 Aug 26;412(2):203-6. doi: 10.1016/j.bbrc.2011.07.045. Epub 2011 Jul 22.

PMID:
21798238
8.

Identification of inhibitors that block vaccinia virus infection by targeting the DNA synthesis processivity factor D4.

Nuth M, Huang L, Saw YL, Schormann N, Chattopadhyay D, Ricciardi RP.

J Med Chem. 2011 May 12;54(9):3260-7. doi: 10.1021/jm101554k. Epub 2011 Apr 19.

9.

Malaria immunoepidemiology in low transmission: correlation of infecting genotype and immune response to domains of Plasmodium falciparum merozoite surface protein 3.

Jordan SJ, Oliveira AL, Hernandez JN, Oster RA, Chattopadhyay D, Branch OH, Rayner JC.

Infect Immun. 2011 May;79(5):2070-8. doi: 10.1128/IAI.01332-10. Epub 2011 Mar 7.

10.

Phylogenetic lineage and pilus protein Spb1/SAN1518 affect opsonin-independent phagocytosis and intracellular survival of Group B Streptococcus.

Chattopadhyay D, Carey AJ, Caliot E, Webb RI, Layton JR, Wang Y, Bohnsack JF, Adderson EE, Ulett GC.

Microbes Infect. 2011 Apr;13(4):369-82. doi: 10.1016/j.micinf.2010.12.009. Epub 2011 Jan 14.

PMID:
21238599
11.

Structure of Plasmodium falciparum ADP-ribosylation factor 1.

Cook WJ, Smith CD, Senkovich O, Holder AA, Chattopadhyay D.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2010 Nov 1;66(Pt 11):1426-31. doi: 10.1107/S1744309110036997. Epub 2010 Oct 27.

12.

Vaccinia virus D4 mutants defective in processive DNA synthesis retain binding to A20 and DNA.

Druck Shudofsky AM, Silverman JE, Chattopadhyay D, Ricciardi RP.

J Virol. 2010 Dec;84(23):12325-35. doi: 10.1128/JVI.01435-10. Epub 2010 Sep 22.

13.

Synthesis and characterization of potent inhibitors of Trypanosoma cruzi dihydrofolate reductase.

Schormann N, Velu SE, Murugesan S, Senkovich O, Walker K, Chenna BC, Shinkre B, Desai A, Chattopadhyay D.

Bioorg Med Chem. 2010 Jun 1;18(11):4056-66. doi: 10.1016/j.bmc.2010.04.020. Epub 2010 Apr 9.

PMID:
20452776
14.

Structures of dihydrofolate reductase-thymidylate synthase of Trypanosoma cruzi in the folate-free state and in complex with two antifolate drugs, trimetrexate and methotrexate.

Senkovich O, Schormann N, Chattopadhyay D.

Acta Crystallogr D Biol Crystallogr. 2009 Jul;65(Pt 7):704-16. doi: 10.1107/S090744490901230X. Epub 2009 Jun 20.

PMID:
19564691
15.
16.

Crystal structure of vaccinia virus uracil-DNA glycosylase reveals dimeric assembly.

Schormann N, Grigorian A, Samal A, Krishnan R, DeLucas L, Chattopadhyay D.

BMC Struct Biol. 2007 Jul 2;7:45.

17.

Structure of a complex of human lactoferrin N-lobe with pneumococcal surface protein a provides insight into microbial defense mechanism.

Senkovich O, Cook WJ, Mirza S, Hollingshead SK, Protasevich II, Briles DE, Chattopadhyay D.

J Mol Biol. 2007 Jul 20;370(4):701-13. Epub 2007 May 10.

PMID:
17543335
18.

Structures of vaccinia virus dUTPase and its nucleotide complexes.

Samal A, Schormann N, Cook WJ, DeLucas LJ, Chattopadhyay D.

Acta Crystallogr D Biol Crystallogr. 2007 May;63(Pt 5):571-80. Epub 2007 Apr 21.

PMID:
17452782
19.

Selective phosphorylation of antiviral drugs by vaccinia virus thymidine kinase.

Prichard MN, Keith KA, Johnson MP, Harden EA, McBrayer A, Luo M, Qiu S, Chattopadhyay D, Fan X, Torrence PF, Kern ER.

Antimicrob Agents Chemother. 2007 May;51(5):1795-803. Epub 2007 Feb 26.

20.

The structure of the Plasmodium falciparum EBA175 ligand domain and the molecular basis of host specificity.

Chattopadhyay D, Rayner J, McHenry AM, Adams JH.

Trends Parasitol. 2006 Apr;22(4):143-5. Epub 2006 Feb 23.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk